News Headlines Article

HRSA rule clarifies hospitals’ ability to purchase orphan drugs at discount
Modern Healthcare

A new regulation will allow certain hospitals to buy orphan drugs at deeply discounted prices if they’re used to treat non-orphan conditions or diseases. The rule, issued earlier this week by the Health Resources and Services Administration, seeks to clarify a statute that excluded these facilities from purchasing drugs designated for a rare disease or condition at 340B prices. The 340B federal drug discount program requires drug manufacturers to provide eligible healthcare providers with discounts on what are called covered outpatient drugs.

 

Commands